0001181431-14-005332.txt : 20140205 0001181431-14-005332.hdr.sgml : 20140205 20140205191604 ACCESSION NUMBER: 0001181431-14-005332 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140205 FILED AS OF DATE: 20140205 DATE AS OF CHANGE: 20140205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AFEYAN NOUBAR CENTRAL INDEX KEY: 0001222012 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 14577609 MAIL ADDRESS: STREET 1: 1 SUNSET RIDGE CITY: LEXINGTON STATE: MA ZIP: 02173 3 1 rrd401010.xml FORM 3 X0206 3 2014-02-05 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001222012 AFEYAN NOUBAR C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 1 0 0 0 No securities are beneficially owned 0 D Mr. Afeyan does not own shares in his individual capacity. He is a manager of Flagship Ventures 2007 General Partner LLC ("Fund 2007 GP"), the sole general partner of Flagship Ventures Fund 2007, L.P. ("Flagship 2007"), and a manager of Flagship Ventures Fund IV General Partner LLC ("Fund IV GP"), the sole general partner of each of Flagship Ventures Fund IV, L.P. ("Flagship IV"), and Flagship Ventures Fund IV-Rx, L.P ("Flagship IV-Rx"). Flagship 2007, Flagship IV and Flagship IV-Rx (collectively, the "Funds") are reporting persons and, concurrently herewith, are jointly filing a Form 3 reporting their ownership in certain of the Issuer's derivative and non-derivative securities (collectively, the "Fund Shares"). As a manager of Fund 2007 GP and Fund IV GP, Mr. Afeyan may be deemed to share voting and investment power with respect to the Fund Shares. Mr. Afeyan disclaims beneficial ownership of the Fund Shares, except to the extent of his pecuniary interest therein. /s/ Noubar B. Afeyan, Ph.D. 2014-02-05